Skip to content

Total body irradiation, cyclophosphamide and imported Tiotepa for conditioning chemotherapy of pediatric refractory malignancy

Total body irradiation, cyclophosphamide and imported Tiotepa for conditioning chemotherapy of pediatric refractory malignancy - Total body irradiation, cyclophosphamide and imported Tiotepa

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004969
Enrollment
5
Registered
2011-02-14
Start date
2011-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric with refractory malignancy

Interventions

imported Thiotepa

Sponsors

YOKOHAMA CITY UNIVERSITY SCHOOL OF MEDICINE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: not poor general condition with malignancy

Exclusion criteria

Exclusion criteria: poor general condition with malignancy

Design outcomes

Primary

MeasureTime frame
safty of treatment

Secondary

MeasureTime frame
curative effect

Countries

Japan

Contacts

Public ContactKato Hiromi

YOKOHAMA CITY UNIVERSITY SCHOOL OF MEDICINE PEDIATRICS

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026